Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Fe3O4@MoS2/RGO as an effective nano-electrocatalyst toward electrochemical hydrogen evolution reaction and methanol oxidation in two settings for fuel cell application.

Askari MB, Beheshti-Marnani A, Seifi M, Rozati SM, Salarizadeh P.

J Colloid Interface Sci. 2019 Mar 1;537:186-196. doi: 10.1016/j.jcis.2018.11.019. Epub 2018 Nov 8.

PMID:
30445348
2.

Deposition of Nanostructured CdS Thin Films by Thermal Evaporation Method: Effect of Substrate Temperature.

Memarian N, Rozati SM, Concina I, Vomiero A.

Materials (Basel). 2017 Jul 9;10(7). pii: E773. doi: 10.3390/ma10070773.

3.

Where does magnetic resonance imaging stand in the diagnosis of knee injuries?

Rastegar S, Motififard M, Nemati A, Hosseini NS, Tahririan MA, Rozati SA, Sepiani M, Moezi M.

J Res Med Sci. 2016 Jul 29;21:52. eCollection 2016.

4.

Experimental treatment strategies in primary cutaneous T-cell lymphomas.

Rozati S, Kim YH.

Curr Opin Oncol. 2016 Mar;28(2):166-71. doi: 10.1097/CCO.0000000000000272. Review.

PMID:
26844985
5.

Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.

Rozati S, Cheng PF, Widmer DS, Fujii K, Levesque MP, Dummer R.

Clin Cancer Res. 2016 Apr 15;22(8):2020-31. doi: 10.1158/1078-0432.CCR-15-1435. Epub 2015 Dec 9.

6.

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

Mangana J, Cheng PF, Schindler K, Weide B, Held U, Frauchiger AL, Romano E, Kähler KC, Rozati S, Rechsteiner M, Moch H, Michielin O, Garbe C, Hauschild A, Hoeller C, Dummer R, Goldinger SM.

PLoS One. 2015 Oct 1;10(10):e0139438. doi: 10.1371/journal.pone.0139438. eCollection 2015.

7.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

Kim YH, Tavallaee M, Sundram U, Salva KA, Wood GS, Li S, Rozati S, Nagpal S, Krathen M, Reddy S, Hoppe RT, Nguyen-Lin A, Weng WK, Armstrong R, Pulitzer M, Advani RH, Horwitz SM.

J Clin Oncol. 2015 Nov 10;33(32):3750-8. doi: 10.1200/JCO.2014.60.3969. Epub 2015 Jul 20.

8.

The physiological responses of the Caspian kutum (Rutilus frisii kutum) fry to the static magnetic fields with different intensities during acute and subacute exposures.

Loghmannia J, Heidari B, Rozati SA, Kazemi S.

Ecotoxicol Environ Saf. 2015 Jan;111:215-9. doi: 10.1016/j.ecoenv.2014.10.020. Epub 2014 Oct 29.

PMID:
25450936
9.

Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS.

Rozati S, Kempf W, Ostheeren-Michaelis S, Bode-Lesniewska B, Zimmermann DR, Dummer R, Cozzio A.

J Clin Oncol. 2016 Apr 10;34(11):e93-6. doi: 10.1200/JCO.2013.51.6559. Epub 2014 Sep 29. No abstract available.

PMID:
25267751
10.

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).

Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH.

Ann Oncol. 2014 Sep;25(9):1807-12. doi: 10.1093/annonc/mdu231. Epub 2014 Jun 19.

PMID:
24948692
11.

Novel therapies for cutaneous T-cell lymphoma: what does the future hold?

Guenova E, Hoetzenecker W, Rozati S, Levesque MP, Dummer R, Cozzio A.

Expert Opin Investig Drugs. 2014 Apr;23(4):457-67. doi: 10.1517/13543784.2014.876407. Epub 2014 Jan 8. Review.

PMID:
24397291
12.

Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas.

Dummer R, Rozati S, Guenova E, Cozzio A.

Future Oncol. 2013 Aug;9(8):1061-4. doi: 10.2217/fon.13.87. No abstract available.

PMID:
23902236
13.

Basal cell carcinoma: a paradigm for targeted therapies.

Dreier J, Felderer L, Barysch M, Rozati S, Dummer R.

Expert Opin Pharmacother. 2013 Jul;14(10):1307-18. doi: 10.1517/14656566.2013.798644. Epub 2013 May 8. Review.

PMID:
23656611
14.

RASopathic skin eruptions during vemurafenib therapy.

Rinderknecht JD, Goldinger SM, Rozati S, Kamarashev J, Kerl K, French LE, Dummer R, Belloni B.

PLoS One. 2013;8(3):e58721. doi: 10.1371/journal.pone.0058721. Epub 2013 Mar 14.

15.

Melanoma immunotherapy: historical precedents, recent successes and future prospects.

Raaijmakers MI, Rozati S, Goldinger SM, Widmer DS, Dummer R, Levesque MP.

Immunotherapy. 2013 Feb;5(2):169-82. doi: 10.2217/imt.12.162. Review.

PMID:
23413908
16.

Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy.

Rozati S, Naef L, Levesque MP, French LE, Dummer R.

J Immunother. 2013 Jan;36(1):52-6. doi: 10.1097/CJI.0b013e31827809c7.

PMID:
23211621
17.

Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumor.

Rozati S, Kerl K, Kempf W, Tinguely M, Zimmermann DR, Dummer R, Cozzio A.

J Cutan Pathol. 2013 Jan;40(1):56-60. doi: 10.1111/cup.12017. Epub 2012 Nov 20.

PMID:
23167279
18.

Cutaneous peripheral T-cell lymphomas, unspecified/NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas.

Kempf W, Rozati S, Kerl K, French LE, Dummer R.

G Ital Dermatol Venereol. 2012 Dec;147(6):553-62. Review.

PMID:
23149701
19.

From chemotherapy to targeted treatment.

Dummer R, Rozati S, Eggmann N, Rinderknecht J, Goldinger SM.

Ann Oncol. 2012 Sep;23 Suppl 10:x101-3.

20.

Cutaneous drug eruptions associated with the use of new oncological drugs.

Belloni B, Schönewolf N, Rozati S, Goldinger SM, Dummer R.

Chem Immunol Allergy. 2012;97:191-202. doi: 10.1159/000335632. Epub 2012 May 3.

PMID:
22613863
21.

Hierarchically assembled ZnO nanocrystallites for high-efficiency dye-sensitized solar cells.

Memarian N, Concina I, Braga A, Rozati SM, Vomiero A, Sberveglieri G.

Angew Chem Int Ed Engl. 2011 Dec 16;50(51):12321-5. doi: 10.1002/anie.201104605. Epub 2011 Sep 26. No abstract available.

PMID:
21953715

Supplemental Content

Loading ...
Support Center